Login to Your Account

AM-Pharma Returns to Clinic With Kidney Injury Drug

By Nuala Moran
Staff Writer

Wednesday, September 25, 2013
LONDON – Two years after halting development of bovine alkaline phosphatase, AM-Pharma is back in the clinic with its new recombinant human version of the anti-inflammatory enzyme.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription